FindMyKOL

Ravi Paluri, MD

Basic profile

Atrium Health Wake Forest Baptist

ORCID↗NPI↗
✓ Full record
RegionWinston Salem, NC · SoutheastSpecialtyHematology / OncologyFocusOncology
Active KOLFindMyKOL type: NationalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ravi Paluri is an Oncology physician affiliated with Atrium Health Wake Forest Baptist. OpenAlex indexes 149 publications with 2,117 citations (h-index 18); ClinicalTrials.gov lists 4 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
149publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,117citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Medical Center Blvd
Winston Salem, NC 271571900

Telephone

336-716-2255

Provider last certified this registry record 17 Jul 2020.

View the NPPES registry record

Clinical trials

All 4 trial records: search, sort and filter.Explore →

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

All 16 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    44.4%
    Factor Xa inhibitor44.4%
    Eliquis100%
    Part D<11 patients

  • Metabolism & gastrointestinal

    28.9%
    Serotonin-3 Receptor Antagonist28.9%
    Ondansetron Hcl100%
    Part D≥12 patients

  • Nervous system

    26.7%
    Phenothiazine26.7%
    Prochlorperazine Maleate100%
    Part D<11 patients
Where care is delivered (Part B)73.2% facility · 26.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 50 publications: search, sort and filter.Explore →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”